BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 19564142)

  • 21. Polyisoprene matrix for progesterone release: in vitro and in vivo studies.
    Heredia V; Bianco ID; Tríbulo H; Tríbulo R; Seoane MF; Faudone S; Cuffini SL; Demichelis NA; Schalliol H; Beltramo DM
    Int J Pharm; 2009 Dec; 382(1-2):98-103. PubMed ID: 19699285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between the FT-IR characteristics and metoprolol tartrate release of methylcellulose-based patches.
    Papp J; Horgos J; Szente V; Zelkó R
    Int J Pharm; 2010 Jun; 392(1-2):189-91. PubMed ID: 20371276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and drug release investigation of amorphous drug-hydroxypropyl methylcellulose composites made via supercritical carbon dioxide assisted impregnation.
    Gong K; Rehman IU; Darr JA
    J Pharm Biomed Anal; 2008 Dec; 48(4):1112-9. PubMed ID: 18922658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
    Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
    Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
    Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
    Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microwave non-destructive testing technique for characterization of HPMC-PEG 3000 films.
    Wong TW; Deepak KG; Taib MN; Anuar NK
    Int J Pharm; 2007 Oct; 343(1-2):122-30. PubMed ID: 17597317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
    Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastroretentive drug delivery systems with L-dopa based on carrageenans and hydroxypropylmethylcellulose.
    Dorożyński P; Kulinowski P; Mendyk A; Jachowicz R
    Int J Pharm; 2011 Feb; 404(1-2):169-75. PubMed ID: 21095225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
    Ige PP; Gattani SG
    Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of Metolose structure on the free volume and the consequent metoprolol tartrate release of patches.
    Papp J; Marton S; Süvegh K; Zelkó R
    Int J Biol Macromol; 2009 Jan; 44(1):6-8. PubMed ID: 18940196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
    Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
    Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.